Megakaryon Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 12

Employees

  • Latest Deal Type
  • M&A

Megakaryon General Information

Description

Developer of a regenerative medicine platform designed to produce engineered platelets and extracellular vesicles from iPSC-derived megakaryocyte cell banks. The company offers standardized, scalable cell manufacturing processes based on induced pluripotent stem cells, enabling researchers and clinicians in transfusion medicine and cell therapy to access consistent, lab-grown blood components for therapeutic and research applications.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Kyoto Research Park Building Number 2
  • 134 Chudojiminami-machi, Shimogyo-ku
  • Kyoto, 600-8813
  • Japan
+81
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • Kyoto Research Park Building Number 2
  • 134 Chudojiminami-machi, Shimogyo-ku
  • Kyoto, 600-8813
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Megakaryon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 21-Dec-2023 Completed Pre-Clinical Trials
6. Accelerator/Incubator Completed Pre-Clinical Trials
5. Later Stage VC (Series D) 17-Feb-2020 Completed Pre-Clinical Trials
4. Accelerator/Incubator 01-Jun-2018 Completed Pre-Clinical Trials
3. Later Stage VC (Series C) 04-Jan-2018 Completed Pre-Clinical Trials
2. Early Stage VC (Series B) 23-Mar-2015 $20.8M $37.1M Completed Startup
1. Early Stage VC (Series A) 26-Aug-2013 $16.4M $16.4M Completed Startup
To view Megakaryon’s complete valuation and funding history, request access »

Megakaryon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a regenerative medicine platform designed to produce engineered platelets and extracellular vesicles from i
Biotechnology
Kyoto, Japan
12 As of 2026

Saint-Sulpice, Switzerland
 

Tokyo, Japan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Megakaryon Competitors (4)

One of Megakaryon’s 4 competitors is HemostOD, a Venture Capital-Backed company based in Saint-Sulpice, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
HemostOD Venture Capital-Backed Saint-Sulpice, Switzerland
AdipoSeeds Venture Capital-Backed Tokyo, Japan
DewCell Venture Capital-Backed Seongnam, South Korea
HemaCell Venture Capital-Backed Suzhou, China
To view Megakaryon’s complete competitors history, request access »

Megakaryon Patents

Megakaryon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026159689-A Composition Pending 19-Mar-2025
WO-2025178117-A1 Composition for use in suppressing differentiation into osteoclasts Pending 21-Feb-2024
WO-2025173790-A1 Bone-forming composition Pending 14-Feb-2024
WO-2023153401-A1 Agitation device for producing platelet, and control method for said agitation device Inactive 10-Feb-2022
AU-2022292342-A1 Method for producing multinucleated megakaryocyte with enhanced platelet production capability, method for producing platelets, method for producing platelet preparation, and method for producing blood preparation Pending 18-Jun-2021 C12N5/0644
To view Megakaryon’s complete patent history, request access »

Megakaryon Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Megakaryon Former Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
CMIC Holdings Holding Company Minority
DBJ Capital Corporate Venture Capital Minority
Innovation Network Corporation of Japan Growth/Expansion Minority
J-Startup Accelerator/Incubator
Japan Asia Investment PE/Buyout Minority
You’re viewing 5 of 19 investors. Get the full list »

Megakaryon FAQs

  • When was Megakaryon founded?

    Megakaryon was founded in 2011.

  • Where is Megakaryon headquartered?

    Megakaryon is headquartered in Kyoto, Japan.

  • What is the size of Megakaryon?

    Megakaryon has 12 total employees.

  • What industry is Megakaryon in?

    Megakaryon’s primary industry is Biotechnology.

  • Is Megakaryon a private or public company?

    Megakaryon is a Private company.

  • What is Megakaryon’s current revenue?

    The current revenue for Megakaryon is .

  • How much funding has Megakaryon raised over time?

    Megakaryon has raised $95.5M.

  • Who are Megakaryon’s investors?

    CMIC Holdings, DBJ Capital, Innovation Network Corporation of Japan, J-Startup, and Japan Asia Investment are 5 of 19 investors who have invested in Megakaryon.

  • Who are Megakaryon’s competitors?

    HemostOD, AdipoSeeds, DewCell, and HemaCell are competitors of Megakaryon.

  • When was Megakaryon acquired?

    Megakaryon was acquired on 21-Dec-2023.

  • Who acquired Megakaryon?

    Megakaryon was acquired by Sysmex (Diagnostic Equipment).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process